Direct Healthcare Professional Communication (DHPC) on Furosemid-hameln 10 mg/ml (250 mg in 25 ml; 10 x 25 ml ampoules; PZN 16833989): visible particles
2023.12.12
Active substance: furosemide
hameln pharma GmbH, in coordination with the Hanover State Trade Supervisory Office (GAA), informs you that the ampoules of the affected batches mentioned in the Red-Hand-Letter must be visually checked for the absence of particles before use. The solution may only be used if it is free of visible particles and the container is undamaged and intact.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN